Remove Funding Remove Invest Remove San Diego Remove Thousand Oaks
article thumbnail

Ocean Aero Gets Investment From Teledyne For Ocean Robots

socalTECH

San Diego-based Ocean Aero , a developer of unmanned, autonomous marine vehicles, has scored funding from Thousand Oaks-based Teledyne , the companies said this morning. Financial terms of the investment were not disclosed. According to Teledyne, the investment also included a strategic partnership deal.

article thumbnail

VC Invest $587M In SoCal In Q4, But National Investments Drop 47 Percent In 2009

socalTECH

invested in Southern California in Q4. was invested in Southern California, as well as Q4 of last year, when $508.2M was invested in the region. However, nationally, venture capital numbers were much worse, with venture investments dropping to the lowest level in more than a decade. in investments. in investments.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

VC Invest $587M In SoCal In Q4, But National Investments Drop 37 Percent In 2009

socalTECH

invested in Southern California in Q4. was invested in Southern California, as well as Q4 of last year, when $508.2M was invested in the region. However, nationally, venture capital numbers were much worse, with venture investments dropping to the lowest level in more than a decade. in investments. in investments.

article thumbnail

Bio Roundup: Mylan’s Shock, Hillary’s 3%, Duchenne Lessons & More

Xconomy

—Amgen (NASDAQ: AMGN ) of Thousand Oaks, CA, said that the FDA rejected its drug etelcalcetide (Parasbiv) , a treatment for patients with an excess of damaging hormone release because of chronic kidney disease. . —A five-day workshop in Washington, D.C., Morgan party.

Pricing 40
article thumbnail

Biotech Roundup: Scangos’s Exit, Zafgen’s Shakeup, Jounce, Relypsa & More

Xconomy

It’s the first partnership for Jounce, and a big one: the startup got a $225 million up front cash payment from Celgene and a $36 million equity investment. —Bruce Bigelow profiled Dauntless Pharmaceuticals , a stealthy biotech company creator in San Diego forming single-drug startups.

Startup 40